Medindia

X

For Post-Stroke Depression, Effects of Xingnao Jieyu Capsules are Similar to Fluoxetine

by Kathy Jones on  August 16, 2013 at 8:21 PM Drug News   - G J E 4
Several biological, psychological, and social factors have been linked to the occurrence of post-stroke depression. These factors involve neurotransmitters, neuroendocrine effects, nerve anatomy, neurotrophic factors, neural regeneration, inflammatory reactions, and social psyche factors.
 For Post-Stroke Depression, Effects of Xingnao Jieyu Capsules are Similar to Fluoxetine
For Post-Stroke Depression, Effects of Xingnao Jieyu Capsules are Similar to Fluoxetine
Advertisement

Synaptotagmin promotes neurotransmitter release, regulates the transfer of synaptic vesicle to synaptic active zones, and is a key factor in information transfer among neurons. The Xingnao Jieyu capsule has been shown to effectively relieve neurologic impairments and lessen depression. It remains poorly understood whether this capsule can be used to treat post-stroke depression. Thus, Prof. Yongmei Yan and team from Shaanxi University of Chinese Medicine found that the Xingnao Jieyu capsules upregulated synaptotagmin expression in the hippocampi of rats with post-stroke depression, and improved depression symptoms. The therapeutic effects of Xingnao Jieyu capsules were similar to those of fluoxetine. These results, published in the Neural Regeneration Research (Vol. 8, No. 19, 2013), can provide scientific evidence and theoretical basis for pathogenesis and treatment of post-stroke depression.

Advertisement


Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: